ArticleBone marrow transplantation2021

Thiotepa-busulfan-fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT.

Giorgia Battipaglia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.